Repatha 140 mg solution for injection in pre-filled pen
APHP201075
Approved small_molecule active
Quick answer
Repatha 140 mg solution for injection in pre-filled pen for acute myocardial infarction is a Approved program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- acute myocardial infarction
- Phase
- Approved
- Modality
- small_molecule
- Status
- active